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Evidence for an essential role of the HSV-1 tegument protein VP1-2 originated 
from the analysis of the temperature-sensitive mutant tsB7. At the non-
permissive temperature (NPT), tsB7 capsids accumulate at the nuclear pore 
with defective genome release and substantially reduced virus gene 
expression. We compare the UL36 gene of tsB7 with the parental strain 
HFEM or strain 17 and identify four amino acid substitutions, 1061D>G, 
1453Y>H, 2273Y>H and 2558T>I.  We transferred the UL36 gene from tsB7, 
HFEM or strain 17, into a KOS background.  While KOS recombinants 
containing the HFEM or strain 17 UL36 genes exhibited no ts defect, 
recombinants containing the tsB7 UL36 VP1-2, exhibited a 5-log deficiency at 
the NPT. Incubation at the NPT resulted in little or no virus gene expression 
though limited expression could be detected in a highly delayed fashion. 
Using shift-down regimes, gene expression recovered and recapitulated the 
time course normally observed, indicating that the initial block was in a 
reversible pathway.  Using temperature shift-up regimes, a second defect later 
in the replication cycle was also observed in the KOS.ts viruses.  We 
constructed a further series of recombinants which contained subsets of the 4 
substitutions.  A virus containing the w/t residue at position 1453 with the 
other three residues being from tsB7 VP1-2,  exhibited w/t plaquing efficiency. 
Conversely a virus containing the three w/t residues but the single residue 
Y>H at position 1453 from tsB7, exhibited a 4-5 log drop in plaquing efficiency 
and was defective in at both early and late stages of infection. 
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The tegument protein VP1-2 encoded by the UL36 gene of herpes 
simplex virus (HSV) is a key structural component. It is conserved across the 
herpesvirus family, is essential for virus replication and plays multiple roles in 
the virus life cycle including entry, transport and assembly (6, 9, 11, 15, 16, 
18, 28).  VP1-2 is classed as an inner tegument protein and in HSV and 
Pseudorabies virus  (PrV) is tightly bound to the capsid as analysed both 
biochemically during differential extraction protocols and in vivo during entry 
(12, 14, 17, 21, 23, 36).  This tight and selective binding of VP1-2 to capsids 
together with immuno-electron microscopy and fluorescence microscopy of 
VP1-2 on capsids at the earliest stages of infection, supports a role for VP1-2 
in capsid transport within the cytoskeletal architecture and in docking and 
genome release at nuclear pores early in the infectious process.  A key role 
for VP1-2 at the earliest stage on infection is strongly supported by results 
showing the failure of VP1-2 negative capsids to enter nuclei within 
polykaryocytes of infected and uninfected cells created by artificial fusion (28). 
 However it was perhaps early analysis of the HSV temperature 
sensitive (ts), tsB7 which provided the first indication of an essential role for 
VP1-2 in HSV replication (3, 4, 15).   Temperature-sensitive mutants generally 
exhibit a significant reduction in the level or activity of the corresponding gene 
product when the gene is expressed above a certain temperature (the 
restrictive or non-permissive temperature). The analysis of ts mutants 
provides an extremely powerful approach for studying protein function and 
assembly in a wide range of fields.  Many such mutants have been isolated 
and exploited in the field of HSV replication and gene function (5, 8, 10, 26, 
27, 30).     With HSV tsB7, at the NPT replication is blocked at a very early 
stage, virus gene expression does not take place and capsids apparently 
accumulate at the nuclear pore without releasing their genomes.  A second 
defect in tsB7 was identified by using temperature shift experiments, where 
initial infection was carried out at the permissive temperature, allowing entry 
and gene expression, followed by a shift to the NPT. This delayed shift to the 
NPT resulted in a shutoff of late protein synthesis and a substantial reduction 
in production of progeny virus (2, 3).  Mapping of the genetic lesions in tsB7 
was performed by marker rescue which located both defects to a region 
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around 0.501 map units (3).  Although several candidates were proposed (15), 
at the time of the characterisation of tsB7 neither the complete HSV transcript 
map nor genome sequence were available, limiting any definitive identification 
of the gene or genes responsible.   Additional transcript mapping (35, 38), 
together with genome sequencing (20) allowed the subsequent association of 
the tsB7 defects with the UL36 gene encoding VP1-2.  
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Nevertheless, the defect in tsB7 has not been definitively shown to 
reside in the UL36 gene nor have any sequence differences which might 
account for VP1-2 temperature sensitive function been identified. Moreover 
tsB7 was constructed by broad chemical mutagenesis of the parental strain 
HFEM, with a possibility that the virus may contain additional mutations 
potentially compounding interpretation of the ts phenotypes.  Here we 
sequence the UL36 genes from tsB7 and the parental virus, identifying four 
amino acid substitutions which may be responsible for the ts defect and take 
two approaches of either constructing a tsB7 strain with w/t UL36 or 
transferring the UL36 gene from tsB7 to an otherwise w/t backbone in HSV 
strain KOS, to pursue analysis of UL36 function. In particularly from this latter 
approach, we isolated individual recombinants containing the UL36 gene from 
tsB7 and compared these to recombinants in which we introduced the paired 
UL36 gene from the parent strain HFEM. All of the recombinants contained 
the majority of the tsB7 UL36 gene and the associated difference at four 
positions compared to the HFEM gene and all exhibited an almost 5-log 
difference in the ratio of plaque formation at 390C versus 330C in Vero cells.  
We demonstrate a reversible block in virus gene expression in such mutants 
after infection at the NPT and an additional block in virus production later in 
the infection process. By construction of additional recombinants we identify 
the substitution of residue 1453Y>H as solely responsible for the reversible 
temperature phenotypes at entry and assembly. These results are discussed 
in relation to VP1-2 structure-function relationships, the roles of VP1-2 and the 
consequences of its dysfunction.   
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Cells and viruses. Vero, HS30, COS-1 and Hep2 cells were grown in 
Dulbecco’s modified minimal essential medium (DMEM, Gibco) containing 
10% newborn calf serum (NCS) and penicillin and streptomycin. HS30 cells 
contain the HSV-1  strain KOS full-length UL36 gene and have been reported 
to complement the temperature sensitive defect in tsB7 (9).  These cells were 
maintained in DMEM containing 500 μg/ml of geneticin (Gibco). Mutant 
temperature sensitive virus tsB7 and its parental strain HFEM were kind gifts 
of Dr. A. Buchan (15). The UL36 deletion virus, KΔUL36, was propagated on 
the complementing cell line HS30 (9). Plaque size was calculated using Image 
Pro Plus software analysis of at least 50 plaques for each virus strain. 
 
Sequencing of UL36 gene. We first cloned the full length UL36 genes into 
pUC19 following the same strategy as previously described for the plasmid 
pTD1 containing the UL36 gene from strain 17 (1).  For HSV-1 tsB7 or HFEM, 
purified viral DNA was digested with XbaI and SpeI and the fragment 
corresponding to nucleotides 69247 to 80722 isolated and inserted into 
pUC19 digested with XbaI to construct plasmids pFA11 and pFA12.  
Automated sequencing was then performed for sequence determination 
across the complete genes for each strain.  For sequencing of the UL36 gene 
from recombinant viruses, Vero cells were infected at 330C, harvested after 
cytopathic effect and processed for total DNA extraction using QIAamp DNA 
Blood kit (Qiagen).  Automated sequencing was then performed with 
appropriate primers to ensure coverage of the entire gene. Note that the 
numbering of residues in tsB7 in this paper is with reference to the sequence 
of the parental strain HFEM.  For reference position 1061 in tsB7 corresponds 
to position 1066 in the published sequence of UL36 from strain 17, due to a 
short repeat of 5 residues in the strain 17 gene in a poorly conserved proline 
rich region at position 375. Thus the numbering of residues discussed herein 
is decreased by 5 relative to the sequence of strain 17 VP1-2.  
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Construction of recombinant viruses rescuing tsB7 or viruses with 
defined mutations in UL36 in a KOS background. To construct a 
recombinant virus with a rescued UL36 gene in the background of tsB7, the 
plasmid pTD4 encoding UL36 gene from strain 17 was co-transfected with 
purified tsB7 viral DNA. pTD4 was derived from pTD3 (1) by the insertion of a 
short (150 bp) 5’ flanking region of homology upstream of the VP1-2 coding 
region.  To construct recombinant viruses based on HSV-1 strain KOS, but 
containing the potential mutations in UL36 from HSV-1 tsB7, co-transfections 
were performed with purified virus DNA from KΔUL36 together with plasmid 
DNA from either pTD1 (strain 17),  pFA11 (strain tsB7) or pFA12 (strain 
HFEM).  
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To construct viruses containing subsets of the four changes in the tsB7 VP1-2 
we first created chimeric genes, swapping appropriate sections of HFEM or 
tsB7 genes. This was achieved as follows (for reference numbering refers to 
nucleotide positions in the strain 17 genome sequence). The 5’ end of tsB7 
and HFEM UL36 were first excised from pFA11 and pFA12 with HindIII 
(80708) and EcoRI (74916) and ligated into pcDNA3 cut with the same 
enzymes to create pcDNA3HFEM-5’end and pcDNA3tsB7-5’end. The region 
covering the 1061D>G mutation site was excised with SgrAI (76683–80400) 
from both pcDNA3HFEM-5’end and pcDNA3tsB7-5’end and ligated into the 
corresponding swapped 5’end plasmids to create pcDNA3HFEM(1061D>G)-
5’end and pcDNA3tsB7(1061G>D)-5’end plasmids. The 3’end of HFEM and 
tsB7 UL36 were excised from pFA11 and pFA12 with EcoRI (74916–69697), 
cloned into each of the four 5’end constructs to create eight plasmids with 
reconstituted UL36 genes as follows: pcDNA3-HFEM, pcDNA3-tsB7, 
pcDNA3-HFEM/tsB7EcoRI named pCH1, pcDNA3-tsB7/HFEMEcoRI named 
pCH2, pcDNA3-HFEM(1061D>G)/tsB7EcoRI named pCH3, pcDNA3-
tsB7(1061G>D)/HFEMEcoRI named pCH4, pcDNA3-HFEM(1061D>G) 
named pCH5 and pcDNA3-tsB7(1061G>D) named pCH6. Based on the most 
informative constructs to delineate substitutions responsible for the ts 
phenotype, we chose pCH1, pCH3 and pCH4 plasmids to generate the 
recombinant viruses expressing the UL36 genes with defined mutations (see 
Figure 7). 
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For isolation of viruses, co-transfections of plasmid and viral DNAs were 
carried out on subconfluent monolayers of COS cells using the calcium 
phosphate precipitation technique with BES [N,N-bis (2-hydroxyl)-2-
aminoethanesulfonic acid]-buffered saline. Infected cells were screened 4 
days later and the cells and medium harvested after extensive CPE.  After 3 
cycles of freezing/thawing the resulting virus preparation was used to obtain 
pure recombinant viruses stocks by either of two methods. Recombinant 
viruses with a rescued UL36 gene were plaque purified by limiting dilution to 
obtain single plaques per well. Alternatively viruses were isolated after 
infection of confluent monolayers of Vero cells with serial dilutions, at 330C in 
presence of DMEM 2%NCS containing 0.4% agar (Gibco).  Isolated plaques 
were picked and purified by a further three successive rounds of growth and 
single plaque isolations on Vero cells at 330C. 
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Infections and temperature shift assays. For analysis of parental or 
recombinant viruses, cell monolayers were incubated at 40C for 1 h prior to 
adsorption and washed with cold DMEM. The virus inoculum (MOI 5) was 
then added in cold DMEM without serum and after 1 hour at 40C, monolayers 
were washed with cold DMEM and DMEM containing 2% NCS, pre-warmed to 
390C, was then added.  The cells were then further incubated at 330C or 390C 
as indicated.  For temperature shift experiments, infected cultures were 
transferred at different times after infection at 330C up to 390C (shift up), or 
after infection at 390C down to 330C (shift down) for further incubation. 
Cultures were transferred and submerged in a water bath at 390C to control 
the temperature as synchronously and rapidly as possible.  Cultures 
continuously incubated at 330C, or 390C or the shifted samples were 
subsequently harvested at different times for analysis depending of the assay. 
 
Immunofluorescence studies. Immunofluorescence analysis was performed 
exactly as described previously (2) using the following antibodies: VP5 (East 
Coast Bio, 1:500), VP1-2, (αVP1-2NT1r, 1:250) (2). Samples from mock and 
infected cells were collected at times indicated, washed with PBS, fixed with 
methanol for 5 minutes at -200C and blocked with PBSB (PBS containing 10% 
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NCS), supplemented for αVP1-2NT1r with 0.5 mg/ml human IgG (Sigma) for 
1 hour at room temperature. The coverslips were then incubated with the 
primary antibody diluted in PBSB for 45 min at room temperature, washed 
with PBS and incubated with the corresponding fluorochrome-conjugated 
(Alexa 488 or Pierce 549) secondary antibodies for 45 minutes. The 
coverslips were washed with PBS, dried and mounted with Mowiol containing 
anti-fade reagent. Images were collected using either a Zeiss Axiovision 
imaging system and using Zeiss x10  or x100 (Plan-Apochromat, 1.4 
numerical aperture) lenses. Images for each channel were captured 
sequentially with a Retiga 2000R camera using Image Pro plus software. 
Composite illustrations were prepared using Adobe software. Example images 
shown are representative of numerous images gathered for each virus and 
condition. 
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SDS-PAGE and Western blotting. Mock and infected cells were washed in 
PBS, and total lysates prepared by adding SDS lysis buffer containing 25 mM 
DTT. Samples were boiled for 5 minutes and briefly sonicated prior to 
electrophoresis. Equal amounts of sample were separated by SDS-PAGE 
using linear 10% or 3-8% gradient gels and transferred onto nitrocellulose 
membranes (Whatman) for Western blotting. Primary antibodies for 
immunodetection were diluted in PBST (PBS plus 0.1 % Tween 20) containing 
5% non-fat dried milk. Target proteins were visualized using DyLight-
conjugated secondary antibodies (Pierce) and developed using Li-Cor 
Bioscience Odyssey Infrared Imaging System. Odyssey v3.0 software was 
used for quantification of the detected proteins with linearity of measurement 
being confirmed using a standardisation bioassay with serial dilutions of 
sample inputs.  Values of specific viral protein intensities were normalized 
against actin values. Antibodies for Western blotting were used as follows: 
ICP4 (Virusys, 1:1000); ICP8 (a kind gift from Roger Everett, 1:2000), VP5 
(East Coast Bio, 1:3000); and monoclonal anti-actin (Sigma, 1:500).  
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Identification of mutations in the UL36 gene from tsB7. 
The HSV-1 ts mutant virus, tsB7, was derived by chemical mutagenesis of its 
parental strain, HFEM, using bromodeoxyuridine (15).  Two types of defect 
were identified in tsB7.  The first was identified by continuous incubation at the 
NPT (390C) and resulted in capsid accumulation at the nuclear pore, defective 
de-encapsidation of the genome and associated lack of gene expression. A 
second defect later in the replication cycle was identified by allowing infection 
to initially proceed at the permissive temperature (330C) so overcoming the 
very early defect and then shifting infected cells to the NPT. This regime 
resulted in a block to subsequent progression of infection indicating a second 
malfunction beyond the early defect in nuclear pore docking. Both defects 
were mapped by intertypic marker rescue initially using HSV-2 and 
subsequently HSV-1 strain F DNA overlapping SalI, XhoI or BamHI restriction 
fragments, to a region located between 0.501 and 0.503 map units.  The gene 
or genes responsible for the defect were not identified, although the close 
linking of a number of protein products including ICP2, -10, -43 and -44 was 
noted.  Subsequent completion of the HSV sequence  and gene assignment 
(20) together with transcript mapping (35) indicate that the region conferring 
the defect in tsB7 is located within the UL36 gene encoding the large 
tegument protein  VP1-2. 
 To refine analysis of the ts defect and provide information aiding our 
understanding of structure-function relationships within VP1-2, we sequenced 
the entire UL36 genes from tsB7 and its parent strain HFEM and compared 
these to each other, and to available sequence data for w/t HSV-1 strains 17 
and KOS.  While nucleotide substitutions which did not affect amino acid 
sequence were observed between strains,  there were only four changes 
which resulted in amino acid differences between tsB7 UL36 and the parental 
HFEM UL36 (Fig. 1a).   In these four positions (numbered with reference to 
the amino acid sequence of HFEM), 1061D>G, 1453Y>H, 2273Y>H and 
2558T>I, (HFEM residues first),  the HFEM residues were identical in strains 
17 and KOS increasing the significance of the changes in the tsB7 sequence.  
These were the only differences between tsB7 and HFEM resulting in amino 
acid changes in VP1-2.   Interestingly the residue at position 1061 is encoded 
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within a SalI fragment (Figure 1, shaded) that yielded some rescue of the ts 
defect in marker rescue experiments.  The residue 1453 is encoded within a 
XhoI fragment which also yielded some rescue, although a larger SalI 
fragment encompassing this region and the remainder of the gene was unable 
to confer significant rescue (3).  The residue 1061D is within a short island 
showing good conservation across members of the alpha-herpesvirus family, 
although 1061D itself, while present in HSV-2 is not as well conserved (Figure 
1b).  Residues 1453 and 2273 which are both tyrosines, have both been 
substituted to histidines. They are also present in regions of good homology 
and while conserved in HSV-2, (as well as the HSV-1 strains) are not 
themselves conserved across the all alpha-herpesvirus family members.   
However at these positions, all the homologues, if not Y, have bulky 
hydrophobic residues F, L, or I.  The residue 2558T while conserved in HSV-
2, is towards the C-terminus of the protein and in a much more highly variable 
region not at all conserved between homologues. 
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Construction of a rescued recombinant mutant virus based on tsB7. 
 Having identified these four amino acid changes in the tsB7 VP1-2, we 
first wished to rescue the defect in tsB7 by recombining into the tsB7 
backbone a defined UL36 gene from a w/t virus.  Purified DNA from tsB7 was 
co-transfected with a linearised plasmid (pTD4) containing intact UL36 (from 
strain 17) with a short flanking region on the 5’ side and extending to the XbaI 
site on the 3’ side of the gene.  Virus progeny was isolated at 330C, individual 
isolates plaque purified, amplified and then tested for plaquing ratio at 390C 
versus 330C.    
 A number of isolates showed pronounced recovery of the ts defect in 
plaque formation and isolate tsB7.33a was selected for further 
characterisation. The parental strain HFEM showed a very slight reduction in 
plaque formation at 390C while strain 17 showed a modest increase of 3-4 fold 
(Figure 2a).  Consistent with the original characterisation (15), plaque 
formation for tsB7 was of the order of 5-6 logs reduced at 390C compared to 
330C (Figure 2a).  In contrast for tsB7.33a, plaquing efficiency had recovered 
virtually all of this defect.  We sequenced the UL36 gene from the rescued 
virus tsB7.33a with the results indicating that virtually the entire w/t UL36 had 
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been successfully recombined and that all the four mutations were now 
replaced by the w/t residues. The cross-over at the 5’ end of the gene mapped 
to between residues 1018 and 1061 using nucleotide sequence 
polymorphisms (Figure 2b).    
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 However while the mutations in UL36 were restored to the w/t residues 
and plaquing efficiency was almost completely restored, nevertheless plaque 
formation by tsB7.33a was still different compared to the parental strain 
HFEM.  Although both viruses exhibited a syncitial plaque morphology, plaque 
size for tsB7.33a was significantly smaller at 390C, with plaque formation 
taking 5-6 days, compared to the large HFEM syncitial plaques which merged 
together over the same time frame (Figure 2c).  This difference in plaque was 
still evident at 330C (data not shown) indicating a potential difference between 
tsB7 and HFEM, unrelated to the ts defect mapped to UL36.    
 We also examined infection during single cycle replication after high 
multiplicity infection at 330C or 390C, using the accumulation of candidate 
proteins ICP8 and VP5 as markers for early and late virus protein synthesis 
(Figure 2d). As anticipated, at 390C tsB7 exhibited a pronounced decrease in 
expression of both products, although very minor amounts of ICP8 were 
detectable.   In contrast, infection with tsB7.33a at 390C resulted in substantial 
levels of expression.   Nevertheless, quantitative analysis indicated that levels 
of both proteins were reduced compared to infection at 330C, with the 
reduction being slightly more (4-fold) for VP5 compared to ICP8 (2-fold).   A 
slight reduction in levels of these proteins was also observed at 390C for the 
parental strain, though this was not observed with strain 17.    
 From the sequencing and recombination results we have identified the 
mutations in UL36 which alone, or in combination confer temperature-
sensitivity on the replication of tsB7.  Restoration of UL36 results in a rescue 
in plaquing efficiency of 5-logs, presumably reflecting a combination of rescue 
of the early defect in capsid and the later defect attributed to UL36 function.    
However tsB7.33a exhibited differences from the parental strain HFEM. It is 
possible that this could be due to alterations in other aspects of the genome 
which resulted from the non-specific chemical mutagenesis of HFEM used to 
create tsB7. We next therefore adopted a different approach to exploit the 
utility of the ts defect in UL36 for exploring function, by introducing the UL36 
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gene from tsB7 into the backbone of an otherwise w/t strain, KOS, and 
examining the transfer of temperature sensitivity. 
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Construction of a ts recombinant mutant virus based on KOS. 
 To aid selection of recombinant viruses based on HSV-1 strain KOS, 
but containing the UL36 gene from tsB7, we employed the strain KΔUL36 
which contains an internal deletion of approximately 3.6 kb in the UL36 gene 
(between the KpnI and EcoRV sites, Figure 3).  This virus does not replicate 
in non-complementing cells, and therefore co-transfection with the tsB7 UL36 
gene and selection for growth at 330C would facilitate isolation of KOS viruses 
containing defined UL36 genes for subsequent characterisation.  For 
comparison and as controls we also recombined in the UL36 genes from the 
parental strain HFEM, and from strain 17.  Transfected cells were harvested 
after CPE was observed and recombinant viruses with a rescued UL36 gene 
were isolated after limiting dilution and multiple rounds of plaque purification. 
For the UL36 genes from strains HFEM and 17, we initially isolated three 
independent recombinants, while for the tsB7 UL36 we isolated 15 individual 
recombinants with the aim of increasing the chances of obtaining different 
mutants. Restoration of UL36 with the tsB7 gene must in principle involve 
recombination upstream of the KpnI site and downstream of the EcoRV, 
restoring the sequence between the KpnI site and EcoRV sites including the 
1061 and 1453 residues. Since recombination could occur anywhere 
downstream of the EcoRV site, individual isolates may retain the KOS 
sequence, or recombine in the tsB7 sequence, including the 2273H and 2558I 
residues.   Progeny virus from each co-transfection was isolated, plaque 
purified and amplified.  We then sequenced across the UL36 gene for each of 
the isolates in particular examining for the restoration of the intact UL36 and 
the provenance of the mutations at 1061, 1453, 2273 and 2558 (Figure 3). 
 Transfection of KΔUL36 DNA alone gave rise to isolates containing 
KOS UL36 (Figure 3a).  This is due to a very minor population of w/t KOS 
virus present in the KΔUL36 passaged in the complementing line as indicated 
previously (9).  Co-transfection with UL36 from HFEM resulted in isolates 
containing the HFEM UL36, including the w/t residues 1061D, 1453Y, 2273Y 
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and 2558T.   In all three isolates, the UL36 sequence was that of HFEM, 
which could be differentiated from KOS on the basis of nucleotide 
polymorphisms, at least up to the C-terminal end of UL36, the limit of our 
sequencing analysis (Figure 3b).  Similarly for recombination with the UL36 
from strain 17, each isolate contained the strain 17 sequence including the 
1061D, 1453Y, 2273Y and 2558T (Figure 3c).  All isolates from the co-
transfections with the UL36 from tsB7, contained the full tsB7 UL36 sequence 
(Figure 3d), including mutant residues 1061G, 1453H, 2273H and 2558I, 
(except one isolate for which sequence data at towards the 3’ end was 
incomplete).   Unfortunately we did not obtain any reassortants in which an 
isolate contained the tsB7 UL36 at 1061G and 1453H  together with KOS 
sequences towards the 3’ end (thus including the KOS 2273H and/or 2558T), 
which might have allowed for subsequent comparative analysis of different 
variants.  
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Characterisation of growth and plaque formation. 
 Viruses were named for the provenance of the UL36 gene, e.g., K.ts-x 
and three independent isolates were initially taken forward for analysis in 
comparison to parental viruses HFEM, tsB7 and KOS,   and to KOS isolates 
containing the HFEM or strain 17 UL36 genes.  
Firstly in terms of plaque formation at 330C versus 390C,  while KOS 
w/t actually exhibited a modest increase in plaque numbers at 390C,  each 
K.tsB7 isolate exhibited a 4-5 log reduction in plaque formation, similar to the 
reduction seen with tsB7 itself (Figure 4a).  In contrast, the KOS recombinants 
with UL36 genes from HFEM or 17, or a revertant of KΔUL36, exhibited no 
temperature sensitivity and again if anything showed an increase in plaque 
number of between 4 and 8-fold.  This defect was also observed in single step 
growth curves. For K.HF-B at 330C, maximum yields were obtained 
approximately 25 h after infection while at 390C infection progressed faster, 
resulting in similar or modestly increased final yields.  For K.ts-2, infection 
progressed similarly to K.HF-B at 330C, (though with some reduction in final 
yield), while at 390C, there was essentially no production of infectious virus 
resulting in a final yield ratio at 39/33 of 3-4 log reduction (data not shown).        
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The cell line HS30 is a derivative of Vero cells, containing the UL36 
gene and was originally used to complement the deletion of UL36.   HS30 
cells were also shown to complement growth of tsB7 (9).   We therefore asked 
whether HS30 cells would complement the growth of the K.ts strains (Figure 
4b). The results demonstrate that each of the K.ts strains exhibited 
approximately 3-logs greater efficiency in plaque formation on HS30 cells 
compared to Vero cells, while in comparison the w/t KOS strain, or isolates 
containing the HFEM or strain 17 UL36 genes exhibited a modest 2-3 fold 
increase in plaquing efficiency (Figure 4b). We note that in addition to the 
striking reduction in plaque formation at 390C, plaques formed by the K.ts 
strains at 330C were about 30% the size of those formed by the corresponding 
strain K.HF, with results for K.ts2 shown in Figure 4c.  The smaller plaque size 
indicates that the substitutions in VP1-2 protein sequence confer some 
debilitation in growth even at 330C.   These results taken together provide 
compelling evidence that one or more of the four mutations 1061G, 1453H, 
2273H and 2558I in UL36 confer stringent temperature sensitivity of plaque 
formation, now in the background of the KOS strain.  For further 
characterization we used one isolate of each virus, thereafter named as K.ts-
2, K.HF-B, K.17-A and K.R-3. 
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Characterisation of virus yield and protein expression. 
  We measured the progression of infection at the level of the 
accumulation of representative viral proteins, ICP8 and VP5 initially at a single 
time point.   For K.HF-B and K.R-3, ICP8 and VP5 were detected at both 330C 
and 390C, with a modest reduction at 390C (Figure 4d, lanes 4-6).  In contrast 
for K.ts-2, there was essentially no protein synthesis detected at 390C (Figure 
4d, lanes 1,2, see also Figure 5).  Additional comparative time course analysis 
demonstrated that for K.ts-2, expression could eventually be detected in a 
much reduced and much delayed fashion at 390C. By contrast, for K.HF-B the 
kinetics and relative abundance of ICP8 and VP5 synthesis were similar at the 
two temperatures (see e.g., Fig 4, 5 and data not shown).   
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Defect in K.ts-2 post entry. 420 
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In the original characterisation of tsB7, by allowing the early phase of 
infection to take place at the permissive temperature, and then shifting 
temperature to 390C, a second defect was reported.  Thus while immediate 
early protein synthesis was then observed, late protein synthesis was not 
sustained unless infection was allowed to proceed for a period of 
approximately 4 h at the permissive temperature. To examine recovery of 
gene expression in K.ts-2 we compared expression at a single late time point 
(24h) after continued incubation at 390C, (i.e. where we normally failed to see 
significant gene expression),  with conditions where infection was first initiated 
at 330C for 10 h, then shifted to 390C until harvest (Figure 5).   Expression 
was then examined for representative early and late proteins, ICP8, VP5.  As 
shown above, expression was virtually absent after continued incubation at 
390C (Figure 5a, compare lanes 3,4 to 5,6).  However, incubation at 330C for 
10 h, followed by temperature shift to 390C (lane 7) allowed recovery to 
virtually identical levels to those seen after continual infection at 330C (lane 6).   
Nevertheless, despite protein synthesis now accumulating to virtually normal 
levels in the temperature shift regime, parallel assay of yields on infectious 
virus showed a substantial reduction (approximately 50-fold) from those seen 
at the same time during continuous incubation at the permissive temperature 
(Figure 5b).   
 We previously reported that during infection with tsB7 under the 
temperature shift regime, where infection is initiated at 330C and then shifted 
to 390C allowing late protein synthesis, that VP1-2 is re-localised in a 
characteristic pattern resulting in a prominent and usually single juxtanuclear 
aggregate (2).  Similar experiments were performed with K.ts-2 with the 
results demonstrating a dramatic re-localisation of VP1-2, with the recruitment 
of additional candidate structural proteins e.g. VP5 into a singular prominent 
juxtanuclear aggregate under the temperature shift regime (Figure 5c, 33S, 
arrows).    
Examination of the precise nature of requirement for infection at the 
permissive temperature to allow sustained later gene expression will be 
pursued in future work using K.ts-2. However together these data 
demonstrate that in addition to the defect at early stages in entry, the four 
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residue changes in VP1-2 in K.ts-2 are responsible for a defect(s) in VP1-2 
function at later stages in virus assembly, presumably related to its role in the 
initial stages of inner tegument assembly or capsid transport functions to sites 
of envelopment.      
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Resumption of gene expression during shift down. 
 To begin to address the nature of the block to entry early in infection at 
the NPT we wished to examine whether the block was reversible i.e., that 
after infection and maintenance at 390C, infection and gene expression would 
ensue if infection was resumed at 330C.   To this end we next performed shift-
down experiments wherein infection was initiated at 390C, held at 390C for 
different lengths of time, then shifted down to 330C and incubation continued, 
examining expression levels of ICP4 and ICP8 (Figure 6).  In the control 
samples, robust synthesis of both proteins was detected at 330C (Figure 6a, 
lanes 7-10), and very substantially reduced amounts of ICP4 protein detected 
in a delayed manner at 12 h pi after continuous incubation at 390C (Figure 6a, 
lane 3-6).     Initiation and maintenance of infection at 390C for 0.5 or 2 h, 
followed by shift down and assay at 6-12 h, actually made little detectable 
difference to overall protein levels (Figure 6b, lanes 3-10, c.f., panel a, lanes 
7-10).  This assay is limited by measurement of the amount of increase in 
protein expression between 2 and 6 h, but nevertheless the result indicates 
that maintenance at 390C at least for 2 h did not disrupt subsequent 
progression at 330C, (though it is possible that there may have been some 
effect or delay).     When extending the duration of infection and maintenance 
at 390C to 6 h, as expected there was now a substantial effect on expression 
levels (Figure 6b, lane 12, see also panel a, lane 4). However now upon shift 
down to 330C we could clearly see that expression levels resumed and within 
2 h at 330C, levels of ICP4 and ICP8 were only slightly below those seen upon 
continued synthesis at 330C.  At the least, during the 2 h after shift down to 
330C, expression levels of both ICP4 and ICP8 had accumulated to greater 
levels than the initial 2h infection at 330C, (c.f., panel b, lane12, 13 with panel 
a lane 7).  These results indicate not only that there is a block to the 
progression of infection due to the mutations in VP1-2, but that this block is at 
a reversible and physiologically relevant stage of infection, since shift down 
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allows infection to proceed relatively normally, within the limits of resolution of 
this type of assay.  
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A single amino acid substitution is responsible for ts defects in VP1-2 
function. 
From these results we conclude that k.ts2, with the four defined amino 
acid substitutions, exhibits reversible malfunction in VP1-2 function, resulting 
in defects both at the early stage of infection and later in the infectious cycle.  
While a priori, it may be that a combination of the four substitutions underpins 
the ts property, it was possible that only one mutation was responsible, or that 
the different substitutions contribute in different ways, in particular to the 
possibility that the early versus the late defect may be uncoupled.  To 
examine this, we constructed versions of VP1-2 with different combinations of 
mutations by swapping large restriction fragments of the w/t gene from HFEM 
and the ts gene from tsB7 (see Materials and Methods). Having constructed 
these chimeric genes, they were recombined into KOS.ΔUL36 as before and 
individual recombinants isolated, grown at 330C and the sequence at the 
positions of the 4 residues determined. This created viruses with informative 
subsets of the four substitutions in the original tsB7 UL36. The viruses with 
regard to the four residues were as follows, (summarized in Figure 7): 
K.ts-CH1:    tsB7 at residues 1061 and 1453,  w/t at positions 2273 and 2558 
K.ts-CH3:    tsB7 at residues 1061, 2273 and 2558,  w/t at position 1453 
K.ts-CH4:    tsB7 at residues 1453,  w/t at positions 1061, 2273 and 2558. 
Each of these viruses was then characterized for growth at the 
permissive and restrictive temperatures with consistent results which allowed 
definitive assignment of the substitution responsible for VP1-2 dysfunction 
(Figure 8a).  Thus K.ts-CH1 has only residues 1061G and 1453H from tsB7 
with residues 2273 and 2558 being w/t,  and exhibited virtually the same 5 log 
decrease in plaque formation as K.ts2 or tsB7.  This result indicates that 
residue 1061 or residue 1453, or both, are responsible for the defect.   The 
variant K.ts-CH3 has residues 1061G, 2273H and 2558I all from tsB7, but 
position 1453Y is w/t.  Despite having the tsB7 residues at three of the four 
positions,  K.ts-CH3 exhibited completely normal plaque formation (Figure 
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8a).   The combination of phenotypes from these two variants provide strong 
evidence that residue 1453 is solely responsible for the ts defect.    This 
conclusion is robustly confirmed with analysis of K.ts-CH4 which now contains 
the w/t residues at positions 1061, 2272 and 2558 but the single change 
1453Y>H from tsB7.   Plaque formation by K.ts-CH4 exhibited a virtually 
identical reduction in plaquing efficiency at 390C as K.ts-CH1, K.ts2 or tsB7, of 
the order of 5 logs. 
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The conclusions from these results are firstly that substitution of the 
single residue at 1453 accounts for the defect in VP1-2 function and secondly 
that the requirements within VP1-2 for entry and for the later role in replication 
cannot be separated based on the effect of alteration at 1453.  The results are 
not consistent with a role for the other three positions in the ts defect.  Thus 
K.ts-CH3, with substitutions in these three positions shows completely normal 
plaque formation, and K.ts-CH4 exhibits as much of a reduction in plaque 
formation as K.ts2 itself or K.ts-CH4.   To confirm this proposition, we 
analysed the defect in gene expression during high multiplicity experiments at 
the NPT (Figure 8b) and the defect under the shift-up regime as described 
above (Figure 8c).  The results (Figure 8b) demonstrate that K.ts-CH4 (single 
substitution 1453Y>H, lanes 11,12)) exhibited the same defect in gene 
expression as seen with K.ts2 (lanes 5,6) or K.ts-CH1 (lanes 7,8)    while K.ts-
CH3 (lanes 9,10), with substitutions at 1061, (and 2273 and 2258) exhibited 
normal gene expression, and as seen above normal plaque formation. 
In the shift-up experiments with K.ts-CH1 and K.ts-CH4, the results 
demonstrate that both viruses exhibited the same defect wherein VP1-2 was 
synthesized but accumulated in a singular prominent juxtanuclear aggregate 
(Figure 8c, 33S, arrows). Conversely K.ts-CH3 exhibited normal cytoplasmic 
localisation. We conclude from these combined data that substitution at 
residue 1453Y>H renders VP1-2 non-functional for its roles in entry at the 
earliest stage of infection and for its role(s) later in infection (Figure 8c).   
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DISCUSSION 554 
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Temperature-sensitive mutations represent useful tools for the 
dissection of function in many diverse processes and ts mutants have been 
isolated and exploited in analysis of HSV replication and gene function (5, 8, 
10, 26, 27, 30).  The utility of the conditional mutation approach is particularly 
useful for study of VP1-2 which has an essential role(s) late in the assembly 
process, as well as roles in early transport and nuclear pore docking.  To 
approach dissection of these roles by the use of deletion mutants, indeed 
even to uncouple and identify its early role in the life cycle, one would have to 
construct mutants which were competent to assemble virus, yet defective in 
the early function.  While this approach may be feasible in the longer term, the 
isolation of a defined ts mutant virus in VP1-2 affords a very useful approach 
to understanding its role in various stages of the virus life cycle.        
The first indication of an essential role of VP1-2 came from examination 
of the phenotype of the temperature sensitive mutant tsB7, which exhibited 
defects very early in virus entry and also later in the replication cycle (3, 15). 
Although both defects were reported by marker-rescue experiments to reside 
in the gene for UL36, confirmation and identification of the mutations 
responsible have not been established.  Here we provide sequence analysis 
of the UL36 gene of tsB7 in comparison to the parental strain HFEM and 
identify mutations leading to four amino acid substitutions 1061D>G, 
1453Y>H, 2273Y>H, and 2558T>I.  In constructing a version of tsB7 with a 
w/t UL36 gene, we show recovery of the efficiency of plaque formation at the 
NPT, but a phenotype in plaque morphology and size persists. This 
observation together with the fact that broad mutagenesis was used to 
generate tsB7, indicates that other features may contribute to the overall 
properties of tsB7.   Therefore we adopted a second approach, constructing a 
recombinant virus based on the KOS strain of HSV-1 and containing the UL36 
gene from tsB7. This virus exhibited a ts phenotype both at the immediate-
early phase, revealed by maintained incubation at the NPT, and a later defect 
revealed by temperature shift–up experiments after infection at the permissive 
temperature.  Finally we constructed a KOS variant containing the single 
1453Y>H which exhibited the same ts defect of approximately 5-logs in 
plaque formation, quantitatively similar to that of tsB7 or that of the KOS 
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variant containing all of the four substitutions.     Conversely a variant 
containing tsB7 mutant residues at 1061, 2272 and 2258,  but the w/t at 1453  
had normal plaquing efficiency, thus providing definitive evidence that the 
single substitution Y>H at position 1453 is responsible for the temperature 
dependent and reversible defect in VP1-2.     
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The identity of this mutation in relation to certain features of the tsB7 
defect and VP1-2 function warrants further discussion.   Consistent with the 
results shown here for the KOS ts strains, we previously reported that in tsB7 
the localisation of VP1-2 is profoundly altered localising to a singular large 
perinuclear cluster, together with associated structural proteins. These 
clusters were seen by electron microscopy to represent coalesced capsids 
which were not progressing to the envelopment stage.  Moreover the clusters 
contained associated accumulation of ubiquitinated protein species. Although 
the target species were not identified and more likely to be species other than 
VP1-2 itself, we speculated on whether the known ubiquitin specific protease 
activity of VP1-2 might be compromised in tsB7.    However what is now clear 
is that the USP region itself contains no amino acid substitutions, and 
considering that the USP can fold and likely function in isolation (31),  we 
believe it unlikely that the substitutions at position 1453, (or the other 
positions) affect the intrinsic USP activity. It remains possible though, that the 
altered intracellular localisation of VP1-2 per se, or alterations in folding of 
other regions of the protein,  affect USP activity or targeting.  Indeed other 
work has indicated the possibility that the defect in tsB7 affects the N-terminal 
region of the protein.  It has been reported that VP1-2 undergoes a proteolytic 
cleavage event early in infection that is related to successful entry (13).  The 
cleavage event resulted in an N-terminal product which although not 
specifically mapped, migrated at approximately 55kDa, and would encompass 
the USP domain and adjacent N-terminal regions.  Infection was blocked by 
an inhibitor of TPCK-like proteases,  with the inhibitor also blocking 
appearance of the VP1-2 cleavage product.  Interestingly the VP1-2 product 
was observed after infection with tsB7 at the permissive temperature but not 
at the NPT.  Thus it is possible that presentation of the putative N-terminal 
cleavage site is influenced by folding determinants including the 1453 residue, 
or that other events requiring the 1453 determinant precede and are 
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necessary for the cleavage event.  Future work will explore the production of 
the N-terminal product in the KOS.ts virus with mutant 1453 and examine any 
effect on USP function. This will require the establishment of in vivo and in 
vitro assays for relevant USP function of the intact protein to explore the 
possibility that the distal amino acid substitutions in VP1-2, specifically 1453, 
affect USP function intrinsically or, e.g. by formation of a dominant negative 
effect,   contributing to the defect in overall VP1-2 function. 
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It seems unlikely to us that the residue at 1453 is required for global 
folding of the entire protein.  As indicated above the USP domain folds in 
isolation and in vivo would be translated and fold much earlier than distal parts 
of the protein.  Large sections of the protein towards the C-terminus can be 
deleted and are obviously dispensable for folding while determinants within 
the last 60 residues are critical (6, 7, 16, 22).  Isolated domains containing the 
C-terminus interact with UL25 and are recruited to assembly sites (16). While 
possible, it would seem unlikely that residue 1453 was involved in folding the 
essential distal C-terminal region beyond the dispensable region.  
Notwithstanding the reported loss of N-terminal cleavage in tsB7,  the region 
at 1453 might be more likely to be involved in formation of a local determinant 
or potentially in intermolecular interactions.   The residue is within a block of 
conservation from approximately 1320 to 1910 whose alignment within the 
alpha-herpesvirus VP1-2 species allows no gaps.  Although residue 1453 is 
not perfectly conserved,  in HSV-1, HSV-2 and MDV this residue is a Y, in the 
other members it is a bulky hydrophobic, within the sequence 
FGAAADTYADMF  (where bold indicates very strong conservation, 
underlined Y at 1453).   Unfortunately there is no simple pattern in the nature 
of the amino acid substitutions that cause temperature sensitivity and 
substitutions that destabilize a candidate protein can be chemically varied 
(19). Nevertheless in those proteins for which there is structural information, 
the locations of temperature-sensitive mutations correlate with low side-chain 
mobility and low surface accessibility (24, 25, 34, 37).  This mutation may 
underpin subtle conformational changes which are revealed at the elevated 
temperature. 
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In relation to defining the ts nature of mutant proteins, early work 
defined two general classes termed TL, for thermolabile mutants, and TSS (or 
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TSF) for mutants displaying temperature-sensitive synthesis (29, 32, 33).  In 
TL mutants an active protein produced at the permissive temperature is 
inactivated upon exposure to the restrictive temperature.  For TSS proteins, 
the substitution appears to affect properties of folding intermediates rather 
than that of the native state.  TSS proteins are not defective if expression 
takes place at the permissive temperature and the proteins are then exposed 
to the restrictive temperature.  Although beyond the scope of the current work, 
we are now in a better position to examine these features in the ts VP1-2 with 
the define mutation.  Having constructed a defined version of the mutation in 
the background of KOS and having a paired strain for comparison, will enable 
a more robust examination of the likely TL properties of the mutant VP1-2 in 
virions (i.e. those properties underpinning the very early defect, where virus 
produced at the permissive temperature displays temperature sensitivity in 
entry, before new protein synthesis).  The defect early in infection has been 
attributed to a defect after entry, at the stage of nuclear pore docking.  
However the TL nature of virions themselves requires further analysis. 
Infectivity of isolated virions may be differentially temperature sensitive 
outside the cell compared to the situation upon detachment from the 
envelope, -and other tegument proteins, after infection, situations clearly likely 
to have differing conformations and interactions for VP1-2. Having constructed 
viruses with defined mutations in a well characterized background, we can 
also undertake a more quantitative approach in attributing the profound 5-log 
decrease in overall plaque formation to different requirements for VP1-2 at the 
early versus the late phases of infection.      
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Finally since we now indentify a single mutation in a reasonably well 
conserved region sufficient for the ts block, it may be possible to generate ts 
versions of VP1-2 in other HSV strains or in other alpha-herpesviruses, which 
will facilitate comparative studies of early entry pathways, assembly pathways 
and the role of VP1-2 in these other contexts. These results and viruses will 
provide useful tools for further analysis of the structure-function relationships 
in VP1-2 and its role(s) at various stages of entry and assembly and in 
determining the outcome of infection.    
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Figure 1. tsB7 UL36 gene contains four amino acid substitutions. (A) 
UL36 genes from tsB7, parental strain HFEM and w/t strain 17 were 
sequenced. Positions of amino acid substitutions (numbered with reference to 
the HFEM sequence, see materials and methods) are indicated together with 
the residues at these positions in tsB7 or the other strains. Features of VP1-2 
illustrated in the diagram include; Ubiquitin-specific-protease (USP); Nuclear 
Localisation Signal (NLS); UL37-binding domain (UL37BD) and the conserved 
C-terminal UL25-binding (UL25BD). The positions of fragments used for 
marker rescue of tsB7  encompassed by SalI or XhoI sites are also indicated 
(3). (B) Sequence homology around the tsB7 substitutions in the VP1-2 
proteins of alphaherpesvirus subfamily members. Alignments were made 
using ClustalX alignment software and illustrated using Genedoc.  Residues 
with complete identity allowing for close chemical similarity are indicated in 
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white text with a black background; over 85% by white text on dark grey, and 
over 50% by black text on light grey.  
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Figure 2. Construction of a recombinant tsB7 virus containing w/t UL36 
gene.  tsB7 DNA was cotransfected with a plasmid encoding w/t UL36 gene 
from 17 strain and the isolate tsB733a further characterized. (A) Restoration 
of plaquing efficiency at 390C. Plaque assay on Vero cells infected at 330C or 
390C with HFEM, tsB7, tsB733a and 17 viruses. The graph shows the relative 
ratio of the plaque formation of each virus. (B) The UL36 gene from tsB733a 
was subcloned and sequenced. Annotation is as for Figure. 1 with diagnostic 
nucleotide polymorphisms allowing sequence attribution shown as (DS). (C) 
Vero cells were infected with dilutions of HFEM and tsB733a viruses, 
incubated at 390C and plates stained with crystal violet. Representative 
images of relative plaque size are shown. (D) Expression of candidate viral 
proteins ICP8 and VP5 expression levels at 330C and 390C in Vero cells 
infected with tsB7, HFEM, tsB733a and strain 17 at moi 5.  For quantitation 
using the Licor Odyssey system, relative levels of each protein were 
normalized with actin levels.  
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Figure 3. UL36 sequence analysis of the KOS recombinant viruses. COS 
cells were cotransfected at 330C with KΔUL36 DNA either alone or with 
pUC19 plasmids encoding UL36 genes from HFEM, 17 or tsB7 strains. 
(KΔUL36 is deleted between the indicated KpnI and EcoRV sites). Several 
isolates from each transfection were purified by successive single plaque 
isolations on Vero cells at 330C.  The resulting viruses were amplified and 
purified viral DNA sequenced. The table shows for each isolate virus the 
identity of the residue at the position of the four substitutions in tsB7, 
organized per transfection group: (A) KΔUL36 transfection alone (i.e., 
revertant KOS viruses K.R-x); (B) KΔUL36 plus HFEM UL36 (K.HF-x); (C) 
KΔUL36 plus strain 17 UL36 (K.17-x) and (D) KΔUL36 plus tsB7 UL36 (K.ts-
x).  Each individual virus was assigned with a specific number or letter. The 
positions of diagnostic polymorphic nucleotide sequences (DS) are also 
indicated which aided in demonstrating the extent of recombined sequences. 
(NI, no sequence information available). 
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Figure 4. Temperature sensitivity of plaque formation by K.ts 
recombinant viruses. (A) Several isolated of each group of KOS 
recombinant viruses were analysed for plaque formation in Vero cells at 390C 
versus 330C. Each of the K.ts isolates exhibited a reduction of approximately 
5 logs in plaque formation.  (B) Complementation of plaque formation in HS30 
cells.  Plaque formation in Vero or HS30 cells was quantitated at 390C and the 
ratio determined.  tsB7 plaque formation was of the order of 3 logs higher in 
HS30 cells, a result also obtained with each of the K.ts isolates.  
Comparatively minor differences were observed for the other strains between 
Vero and HS30 cells. (C) Plaque size for K.HF-B and K.ts-2 viruses at 330C.  
K.ts-2 plaque size was approximately 1/3 of the area of the corresponding 
isolates containing the HFEM UL36 gene.  Plaque size was estimated using 
Image Pro Plus software from approximately 50 plaques for each virus with 
representative images shown by crystal violet staining. (D) Temperature 
sensitivity of gene expression. Vero cells were infected (moi 5) with K.ts-2, 
K.HF-B, K.R-3 or w/t KOS at 330C or 390C, extracts collected at 24 hpi and 
analysed for the accumulation of viral proteins VP5 and ICP8.  Actin levels 
were measured as a loading control.  
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Figure 5. Post-entry defect of K.ts-2.  Monolayers of Hep2 cells were 
infected (moi 5) with K.ts-2 at 330C, and at 10 h one set of cultures was 
maintained at 330C while a duplicate set was shifted up to 390C (33S).  
Incubation was continued and cultures harvested at 24 hpi. (A) Examination of 
candidate virus protein expression (ICP8 and VP5) expressed after 
continuous incubation at 330C (lanes 5,6), 390C (lanes 3,4) or under the shift 
regime (33S, lanes 7). Actin levels were measured as loading control. (B) 
Parallel examination of total virus yield determined by titration on Vero cell 
monolayers at 330C.  Yield under the shift regime was almost 2 logs reduced 
compared to that at 330C (set as 100%). (C) Altered localisation of ts VP1-2 
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after temperature shift.  Hep2 cells were infected with K.ts-2 at 330C, and at 
10 hpi, either maintained at 330C or shifted up to 390C.  The cells were fixed 
at 16 hpi and the localisation of VP1-2 and VP5 analysed.  At 390C, 
pronounced re-localisation of VP1-2, co-localising with VP5 in a single 
juxtanuclear aggregate is evident (arrows). 
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Figure 6. Reversible early defect in K.ts-2 upon temperature shift-down 
assay.  (A) Vero cells were infected with K.ts-2 (moi 5) continuously at 390C 
or 330C,   or (B)  infected at 390C and shifted down to 330C at 0.5 hpi (lanes 3-
6), 2 hpi (lanes 7-10) or 6 hpi (lanes 11-14), and then harvested at the times 
indicated. Total times are indicated. Thus, e.g., for lanes 11-13, samples were 
at 390C for 2 h, at 390C for 6 h (lane 12), and at 390C for 6 h, followed by 2 h 
at 330C (lane13).   Levels of representative immediate-early proteins (ICP4) 
and delayed-early proteins ICP8 are shown together with actin levels as 
loading controls. 
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Figure 7. Construction of the KOS recombinant viruses with selected 
substitutions in VP1-2.  VP1-2 genes were constructed by swapping 
segments of parental HFEM and tsB7 genes using the indicated restriction 
sites (see Materials and Methods), yielding genes with various combinations 
of substitutions (lollipops indicate the presence of a residue from tsB7 UL36, 
absence of a lollipop indicates w/t residues at those positions).  Recombinant 
viruses were then constructed as before by co-transfecting COS cells with 
KΔUL36 DNA with the various plasmids. Isolates from each co-transfection 
were purified by successive single plaque isolations on Vero cells at 330C.  
The resulting viruses were amplified and purified viral DNA sequenced at the 
relevant positions of the four substitutions. Viruses were named for the 
provenance of the UL36 plasmids from which they were constructed i.e., K.ts-
CHx.  
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Figure 8. Identification of a single residue change responsible for the ts 
phenotype of tsB7 and K.ts-2. (A) tsB7, K.ts-2 (containing the four changes 
present in tsB7 UL36) and variants with subsets of these changes were 
analysed for plaque formation in Vero cells at 390C versus 330C.  K.ts-CH1 
and K.ts-CH4 exhibited a reduction of approximately 5 logs in plaque 
formation, while K.ts-CH3 (containing three of the four substitutions but w/t 
1453) exhibited no defect in plaque formation.  (B) Temperature sensitivity of 
gene expression. Vero cells were infected (moi 5) with viruses as indicated at 
330C or 390C, extracts collected at 24 hpi and analysed for the accumulation 
of viral proteins VP5 and ICP8.  Actin levels were measured as a loading 
control.  (C) Altered localisation of ts VP1-2 after temperature shift.  Hep2 
cells were infected with the viruses indicated at 330C, and at 10 hpi, either 
maintained at 330C or shifted up to 390C.  Cells were fixed at 16 hpi and the 
localisation of VP1-2 and VP5 analysed.  At 390C, pronounced re-localisation 
of VP1-2, co-localising with VP5 in a single juxtanuclear aggregate is evident 
(arrows) for K.ts-CH1 and for K.ts-CH4 which contain respectively 1061D>G 
plus 1453Y>H,  or just 1453Y>H. No alteration in VP1-2 localisation was 
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observed for K.ts-CH3 which contains three tsB7 substitutions, but the w/t 
residue at 1453Y. 
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